BGI Genomics Co., Ltd.

300676

CNE100003449

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 2025-12-05			5-day change	1st Jan Change
45.03 ^CNY	+0.83%		-3.47%	+7.29%

Oct. 23	BGI Genomics Widens Q3 Loss, Revenue Rises 9%	MT
Oct. 23	BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

BGI Genomics Gets Registration for Expanded Use of Hereditary Deafness Gene Detection Kit

Published on 09/13/2024 at 12:42 am EDT - Modified on 09/13/2024 at 12:43 am EDT

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about BGI Genomics Co., Ltd.

Oct. 23	BGI Genomics Widens Q3 Loss, Revenue Rises 9%	MT
Oct. 23	BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
Oct. 23	Bgi genomics q3 net loss at 27.2 million yuan	RE
Sep. 21	An undisclosed buyer acquired 4% stake in BGI Genomics Co., Ltd. from Shenzhen Huada Gene Technology Co., Ltd. for Approximately CNY 740 million.	CI
Sep. 12	Bgi Genomics's controlling shareholder to unload 4% stake in company	RE
Aug. 25	BGI Genomics H1 Profit Falls 68%, Revenue Slips 13%	MT
Aug. 22	BGI Genomics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
Aug. 22	Bgi genomics h1 net profit down 68.3% y/y	RE
Apr. 25	BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
Mar. 10	Vazyme Biotech Ties Up With BGI Genomics to Develop Genetic Products	MT
24-10-25	BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
24-09-13	BGI Genomics Gets Registration for Expanded Use of Hereditary Deafness Gene Detection Kit	MT
24-09-11	US Biosecure Act Could Boost South Korean Biotech Companies, Report Says	MT
24-09-11	BGI Genomics to Inject 149 Million Yuan in Equity Investment Fund	MT
24-09-10	China slams US bill targeting biotech firms as 'discriminatory'	RE
24-09-09	US Democrat Congressman to Block Bill Banning Business with Chinese Biotech Firms	MT
24-08-23	BGI Genomics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-07-25	BGI Genomics Announces the Opening of the Astana Genetic Center in Astana, Kazakhstan in Partnership with Technopark Biogen	CI
24-07-23	BGI Genomics Opens Lab in Kazakhstan	MT
24-06-27	BGI Genomics Co., Ltd. Announces Final Cash Dividend Plan on A Shares for the Year 2023, Payable on 4 July 2024	CI
24-06-19	BGI Genomics Co., Ltd. Announces Board Appointments	CI
24-05-20	US Legislation Banning Chinese Biotech Firms Will Suppress Legislation, BGI Says	MT
24-05-10	Bgi Genomics Co., Ltd. Approves Cash Dividend for 2023	CI
24-04-26	BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-15	BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023	CI

BGI Genomics Co., Ltd. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.

Employees

3,702

Sector

Biotechnology & Medical Research

Calendar

Apr. 26 - Q4 2025 Earnings Release (Projected)

More about the company